The optimization of recombinant antibody production in Chinese Hamster Ovary (CHO-K1) cells is a crucial aspect of biopharmaceutical development. To maximize production, various strategies are employed, including genetic engineering of the host cells and optimization of culture conditions. Furthermore, utilization of advanced fermenters can signi